Thrombin Generation Assay
Clinics in Laboratory Medicine · 2026-06 · 46 (2) · 375-387
DOI: 10.1016/j.cll.2026.02.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2026-06. Verfasst von Paul Riley. Beteiligte Einrichtung: Diagnostica Stago Inc., 5 Century Drive, Parsippany, NJ 07054, USA. Electronic address: paul.riley@us.stago.com. Hauptthemen laut MEDLINE: Thrombin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Thrombin generation assay (TGA) is a tool to assess bleeding and thrombotic risk in citrated plasma, either in the presence or absence of platelets, and several different commercial assays have been developed and actively marketed. TGA can be used for various research and clinical applications, including the identification of patients at risk of bleeding or thrombosis, as well as monitoring of treatment in at risk patients. Though current implementation is limited to specialized laboratories in university hospitals and research centers, wider implementation will require additional, large clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diagnostica Stago Inc., 5 Century Drive, Parsippany, NJ 07054, USA. Electronic address: paul.riley@us.stago.com.
Zitieren
APA
Riley, P. (2026). Thrombin Generation Assay. Clinics in Laboratory Medicine, 46(2), 375-387. https://doi.org/10.1016/j.cll.2026.02.010
Vancouver
Riley P. Thrombin Generation Assay. Clinics in Laboratory Medicine. 2026;46(2):375-387. doi:10.1016/j.cll.2026.02.010
BibTeX
@article{Riley2026,
author = {Riley, Paul},
title = {Thrombin Generation Assay},
journal = {Clinics in Laboratory Medicine},
year = {2026},
volume = {46},
number = {2},
pages = {375--387},
doi = {10.1016/j.cll.2026.02.010}
}
EUVIMED